Cardiovascular diseases (CVD) continue to be a major cause Background of death among post-menopausal women. We sought to assess cardiovascular risk among pre-and post-menopausal women living within the Cape Coast Municipality by comparing the lipid profiles and other emerging biomarkers of CVD, i.e. the atherogenic index of plasma (AIP), visceral adiposity index (VAI), body adiposity index (BAI) and Castelli index I (CRI-I).
Introduction
Menopause is a permanent physiological state with cessation of menstruation attributable to the loss of ovarian function and reduction in the production of estrogen 1 . The average age of menopause is reported to be 51 years 2 but the age of natural menopause may vary from 40 to 58 years. This phase is characterized by variety of changes in socio-cultural, physiological and psychological states. These changes culminate into myriad of symptoms including insomnia, sweating, hot flashes, depressive mood, vaginal dryness and general discomfort 3 .
Cardiovascular diseases (CVD) are the major cause of death among post-menopausal women 4 . Studies have shown that premenopausal women have a low risk of CVD as compared to men but after menopause the level of risk increases 5 . Epidemiological data have revealed elevated risk of CVD in postmenopausal females compared to men of the same age 6 . Estrogen is the major female hormone that regulates many aspects of a female's development. Reduced circulating estrogen levels impeded ovulation as results of under stimulation of the hypothalamus to release follicle stimulating hormones 7,8 . Estrogen is known to possess both anti-atherogenic and cardioprotective effect by maintaining high levels of high-density lipoprotein (HDL-C) coupled with decreasing low-density lipoprotein cholesterol (LDL-C), and triglycerides (TG) 9 . Several factors, including diabetes, hypertension, and atherosclerosis among others can lead to CVD in women. The World Health Organization (WHO) has ranked CVDs as the number one cause of death, with global estimation of about 17.7 million deaths in 2015 10 .
Current data have shown that Castelli risk index I and II which are estimated as TC/HDL-C and LDL/HDL-C ratios respectively predict cardiovascular risk accurately than conventional lipid profile indices such as serum TC and serum triglycerides 11, 12 . Similarly, comparison of individual lipid ratios in subjects of the Framingham Heart Study unarguably indicates that lipid ratios are significantly more useful predictors of CVD than the individual levels of LDL or HDL 12 . Many clinical studies have also made efforts to introduce better markers of atherogenic dyslipidemia that can predict the risk of CVD to be useful for evaluating response to treatment instead of the classical ratios 13 . Notable among these markers is the atherogenic index of plasma, which has proven to be a strong marker for the prediction of atherosclerosis and coronary heart disease risk 14 .
Menopausal health has received little attention due to high illiteracy rate, poverty and a possible lack of understanding of the clinical dynamics associated with it, irrespective of the fact that menopause is a key risk factors for dyslipidemia which affects cardiovascular health of women. Compared with men, the diagnosis of CVD in women is difficult due to hormone-related changes and difference in sex in the clinical manifestation of CVD. Such limitations and challenges present the need for an increased consciousness of the significance of CVD as a major public health issue for older women. This study therefore sought to assess the cardiovascular risk between pre and post-menopausal woman in the Cape Coast municipality by comparing the lipid profiles and other emerging biomarkers of CVD such as atherogenic index of plasma visceral adiposity index and basal adiposity index.
Methods

Study area and population
We conducted this comparative cross-sectional study among a convenience sample of 150 women between June 2017 and August 2018 at Cape Coast, the capital of the Central Region of Ghana. No attempts were made to control for bias in recruitment. This Region covers an area of approximately 9826 square kilometres or 4.1% of Ghana's land area. The study participants were apparently healthy pre-and post-menopausal women.
Inclusion criteria
The inclusion criterion used for the study was healthy postmenopausal women aged 40-55 years serving as cases while premenopausal women within the age of 30-40 years were used as comparative controls.
Exclusion criteria
Those with known cardiovascular and metabolic diseases such as hypertension, diabetes, renal or hepatic disorders, menstrual disorders and those on hormonal replacement therapies were excluded from the study. Also, pregnant and lactating women, women with known thyroid diseases, heavy smokers and alcoholics were not included in the research.
Ethical approval and consent to participate Ethical approval for the research was sought from the Institutional Review Board of University of Cape Coast (UCCIRB/ CHAS/2017/83). All information regarding the study including the purpose, risks, procedures, and benefits were made known to the participants before seeking for written informed consent.
Blood sample collection, lipid profile and fasting blood glucose measurement From each participant, 4 mL of venous blood samples were collected from each participant with a sterilized syringe and needle after an overnight fast (12-14 hours) and dispensed into a gel separator tube. Blood samples were analyzed using a fully automated chemistry analyzer (Mindray BS240. Mindray Bio-Medical Electronics Co., Ltd) to estimate the total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), VLDL, TG and non-HDL. Fasting blood glucose was measured with the URIT glucometer (URIT G26 ® , URIT Medical Electronic, UK).
Anthropometric measurements
For body mass index (BMI) estimation, height was measured to the nearest centimetre without shoes with a stadiometer (Seca 217, 40 Barn Street B5 5QB Birmingham, United Kingdom) and weight was measured to the nearest 0.1 kg, with a bathroom scale (Zhongshan Camry Electronic Co. Ltd, Guangdong, China). BMI was calculated as a ratio of weight (kg) to height squared (m 2 ). This was used to categorize participants as underweight (<18 kg/m 2 ), normal (18-24 kg/m 2 ), overweight (25-29.9 kg/m 2 ) and obese (>30 kg/m 2 ) according to WHO criteria 15 .
Measurement of blood pressure Blood pressure measurements were performed according to the American Heart Association recommendations 16 . Measurements of blood pressure were performed using an automatic validated device (Omron HEM711DLX, UK) on the superior left limb. The subjects were made to sit with the legs uncrossed and arm supported at the height of the heart with cuff adapted to the size of the arm. Blood pressure was measured as the mean values of duplicate measurements. Grading of hypertension recorded as follows; "normal" when the systolic blood pressure (SBP) was < 120 mmHg and diastolic blood pressure (DBP) was <80 mmHg "pre-hypertension" when SBP = 120-139 or DBP = 80-89 and "hypertension" when SBP = 140-159 or DBP = 90-99 17 .
Atherogenic indices
Atherogenic indices estimated included AIP (log (TG/HDL), visceral adiposity index (VAI)
non-HDL(TC -HDL) and CRI-I(TC/HDL) 18 .
Data analysis
Data for the study were analyzed using GraphPad prism (6.01) and R statistical software package version 3.0.1. Exploratory analysis was done for descriptive statistical indices such as frequencies, percentages and mean ± standard deviations. Tables were obtained from exploratory analysis. Student's t-test was performed to compare pre and post-menopausal groups for anthropometrics, lipid profiles and atherogenic indices. Fisher's exact test or Chi-square test were employed where deem fit to assess the association between proportions of variables in pre and post-menopausal groups. Crude and adjusted odds ratios (aOR) at 95% confidence interval (CI) were evaluated for Fisher's exact test outcome. Correlation analysis was done using Spearman's rho moment correlation analysis for lipid profile and atherogenic indices among the study participants. Significance level was determined at P<0.05.
Results
Participant background
A total of 150 pre and post-menopausal women were enrolled into the study with a significantly older post-menopausal group (59.63±7.419, P<0.0001) compared to the pre-menopausal group (32.28±8.820). Also, the post-menopausal group had an elevated SBP (P=0.0003), DBP (P=0.0822), FBS (P=0.0004) as well as a higher BMI compared to the pre-menopausal women ( Table 1) . Complete demographic information, alongside all other variables measured, are available as Underlying data 19 .
Cardiovascular and atherogenic markers
Serum TC, TG and NON-HDL-C were significantly increased in post-menopausal women compared to pre-menopausal women (p<0.0001). In addition, there was an observed significant increase in LDL-C (p<0.0001) and VLDL (p=0.0021) levels in the postmenopausal women. In comparison with pre-menopausal women, atherogenic markers (AIP, VAI, BAI and CRI-I) were significantly elevated in post-menopausal women (p<0.0001) ( Table 2 ). Table 3 ).
In post-menopausal women, we report a positive correlation of TC with all the cardiovascular and atherogenic markers except HDL-C whilst HDL-C on the other hand showed a significant negative correlation with all the atherogenic and cardiovascular markers with the exception of BAI, which wasn't significant (Figure 1 ).
Discussion
Although CVD is the major cause of death and disability in women, it usually starts about 10 years late in men of the same age. It is also true that CVD are the major cause of mortality in post-menopausal women 4 . The patterns of dyslipidemia that leads to CVD and its associated complications have been linked with hormonal changes associated with menopause. Estrogen is known to possess both anti-atherogenic and cardioprotective effect by maintaining an acceptable balance between pro/ anti-atherogenic and cardiovascular risk markers 9 . We therefore sought to assess cardiovascular and atherogenic risk among pre and post-menopausal women in the Cape-Coast municipality.
In comparison to pre-menopausal women, we report elevated levels of TC (p<0.0001), VLDL, TG (p<0.0001), LDL-C (p<0.0001) and NON-HDL cholesterol (p<0.0001) in post-menopausal women. This is in line with earlier findings by Pardhe et al., who also reported significantly increased levels of TG, TC, LDL-C and reduced levels of HDL-C among Nepalese women 4 . Adverse changes in lipids and lipoprotein independent of age has been linked to mmenopause 20 . Among all the risk factors for CVD, the major indication suggests an association of estrogen with the observed discrepancies in lipids and lipoproteins 12 . Earlier studies have reported an increase in the release of free fatty acids into circulation due to high-fat accumulation leading to elevated hepatic triglycerides synthesis 21 . In addition, a reduction in estrogen after menopause increases plasma lipoprotein lipase (LPL) and hepatic TG lipase activity thereby causing accumulation of plasma LDL-C 22 . However, HDL-C was significantly decreased in post-menopausal women which is in tandem with the findings of previous studies 23, 24 . Available evidence shows that as HDL-C increases by 0.026 mmol/ml, there is a reduction in risk of cardiovascular diseases, with a 4.7% decrease in mortality rate of CVD 25 . Changes in plasma lipid is known to partly increase the incidence of cardiovascular disease following menopausal transition 20,24 .
Newly emerging atherogenic markers such as AIP, VAI, BAI and CRI-I have been used to assess cardiovascular risk and atherogenicity among various disease states including hypertension 26 , diabetics 27 and among HIV patients 11 . Our results revealed that, markers of atherogenicity including AIP (p<0.0001), VAI (p<0.0001), BAI (p<0.0038) and CRI-I (p<0.0001) were significantly increased in post-menopausal women. This is in line with a study by Nwagha et al., which reported a significantly reduced AIP levels among pre-menopausal women confirming the alteration of lipid profile in menopause 26 . The use of lipid ratios as prognosticators of cardiovascular risk cannot be overemphasized. In fact, variations in lipid ratios such as CRI-I and CRI-II have been reported to be better predictors of risk reduction in coronary heart disease compared to the absolute lipoproteins or lipids 28 . Higher levels of TC, LDL-C, AIP, BAI and CRI-I as well as low levels of HDL-C were all crudely associated with postmenopausal women; however, after correction for age and BMI, AIP was not significantly associated to postmenopausal status with a marked reduction in the significance levels of the other parameters (Table 3 ). This confirms the significant intersection between cardiovascular risk and aging 29 . We also report a positive correlation of TC, TG, and VLDL with atherogenic markers AIP, VAI and CRI-1 in post-menopausal women. Upsurge in the levels of TG in isolation has been shown to increase AIP in women than in men but its influence can be neutralized by the levels of HDL 30 . Others have reported an association of CVD progression with the size of LDL-C and HDL-C, with the lesser size showing great atherogenic potential 31 . There is indeed a strong relationship between cholesterol etherification rate in HDL plasma (FERHDL) and lipoprotein particle sizes, which is considered as a risk marker of coronary artery diseases. Lately, VAI has demonstrated to be a potent marker of adipose distribution and function indirectly conveying cardiometabolic risk 32 . Among post-menopausal women, VAI was shown to predict cardiometabolic risk in association with visceral fat 33 while positively correlating with peripheral glucose usage during euglycemic hyperinsulinemic clamp 32 . Among our study population, post-menopausal women showed increased body adiposity with a high percentage of body fat than pre-menopausal counterparts. An easy but effective determination of adiposity is needed to assess the magnitude of cardiovascular disease for the development of suitable management and preventive strategies. Confirmatory studies in different ethnicities have consistently revealed the overestimation and underestimation of adiposity at low and higher body fat percentages, respectively, by BAI 34 . Therefore, it is important to carefully interpret BAI values along with other anthropometric and cardiovascular markers.
Our results also indicated there was a significant increase in BMI, blood pressure and fasting blood sugar in post-menopausal women in contrast with pre-menopausal women. The increase may be attributed to the reduction in the production of estrogen, which may be associated with amplified cardiovascular risk in post-menopausal women. Surgical or naturally induced menopause increases the risk of CVD 35 and the changeover may be associated with changes in body composition, with a considerable increase in the waist-to-hip ratio during menopause coupled to a possible increase in BMI 36 . Research has demonstrated the upsurge in the release of nitric oxide and the production of prostacyclin within the arterial endothelial cells by estrogen, culminating into the induction of a vasodilatory effect leading to a drop in BP 37 . Furthermore, estrogen again reduces the synthesis of thromboxane A 2 by platelets with vasoconstriction properties 38 . Hence the absence or a reduction in the estrogen levels during menopause may increase blood pressure due to an increase in peripheral resistance. Also, when estrogen production is low, there is reduced stimulation of the liver to synthesize renin. This is a rate-limiting step in the reninangiotensin-aldosterone system leading to vasoconstriction with subsequent increase in blood pressure 39 . On the other hand, urbanization, affluence, changing dietary habits and sedentary lifestyles can also be implicated for the above findings 40 . Even though a significant association of increased cardiovascular risk with post-menopausal status was found in this study, our findings may be limited by the smaller sample size used and hence a larger sample size would have provided more stability to our conclusions.
Conclusion
Menopause could lead to changes in lipid profile in the direction of atherogenicity and increase the risk of CVDs. Atherogenic markers such as AIP, VAI, BAI, and CR can serve as potential biomarkers for predicting CVD and can be used together with other markers.
Data availability
Underlying data Zenodo: Assessment of cardiovascular risk in post-menopausal women in Ghana. http://doi.org/10.5281/zenodo.3228917 19 .
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